Piper Sandler analyst Matt O’Brien lowered the firm’s price target on Cutera to $1 from $3 and keeps a Neutral rating on the shares. The company reported Q2 results that fell short of consensus on the top-line, though met expectations on the bottom-line, the analyst tells investors in a research note. The firm continues to believe Cutera’s turnaround and domestic re-launch could take some time to gain traction.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CUTR: